Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.
Hurst CD, Cheng G, Platt FM, Castro MAA, Marzouka NS, Eriksson P, Black EVI, Alder O, Lawson ARJ, Lindskrog SV, Burns JE, Jain S, Roulson JA, Brown JC, Koster J, Robertson AG, Martincorena I, Dyrskjøt L, Höglund M, Knowles MA. Hurst CD, et al. Among authors: dyrskjot l. Cell Rep Med. 2021 Dec 21;2(12):100472. doi: 10.1016/j.xcrm.2021.100472. eCollection 2021 Dec 21. Cell Rep Med. 2021. PMID: 35028613 Free PMC article.
Molecular profiling of ADAM12 in human bladder cancer.
Fröhlich C, Albrechtsen R, Dyrskjøt L, Rudkjaer L, Ørntoft TF, Wewer UM. Fröhlich C, et al. Among authors: dyrskjot l. Clin Cancer Res. 2006 Dec 15;12(24):7359-68. doi: 10.1158/1078-0432.CCR-06-1066. Clin Cancer Res. 2006. PMID: 17189408
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study.
Dyrskjøt L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, Kotwal S, Knowles M, Malmström PU, de la Torre M, Wester K, Allory Y, Vordos D, Caillault A, Radvanyi F, Hein AM, Jensen JL, Jensen KM, Marcussen N, Orntoft TF. Dyrskjøt L, et al. Clin Cancer Res. 2007 Jun 15;13(12):3545-51. doi: 10.1158/1078-0432.CCR-06-2940. Clin Cancer Res. 2007. PMID: 17575217 Free article.
Gene signatures for risk-adapted treatment of bladder cancer.
Ørntoft TF, Dyrskjøt L. Ørntoft TF, et al. Among authors: dyrskjot l. Scand J Urol Nephrol Suppl. 2008 Sep;(218):166-74. doi: 10.1080/03008880802283730. Scand J Urol Nephrol Suppl. 2008. PMID: 18815931 Review.
High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy.
Jensen JB, Munksgaard PP, Sørensen CM, Fristrup N, Birkenkamp-Demtroder K, Ulhøi BP, Jensen KM, Ørntoft TF, Dyrskjøt L. Jensen JB, et al. Among authors: dyrskjot l. Eur Urol. 2011 May;59(5):841-8. doi: 10.1016/j.eururo.2011.01.048. Epub 2011 Feb 16. Eur Urol. 2011. PMID: 21330047
186 results